Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up.
Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Mori T, Tanaka M, Kondo T, Umemoto Y, Goto H, Yoshioka S, Machida S, Sato T, Katayama Y, Kato S, Shono K, Mizuno I, Fujiwara SI, Kohno A, Takahashi M, Fukuda T. Kurosawa S, et al. Among authors: katayama y. J Cancer Surviv. 2022 Oct;16(5):1004-1015. doi: 10.1007/s11764-021-01092-w. Epub 2021 Aug 27. J Cancer Surviv. 2022. PMID: 34449050
Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.
Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S. Harada K, et al. Among authors: katayama y. Leuk Lymphoma. 2019 Jun;60(6):1493-1502. doi: 10.1080/10428194.2018.1535115. Epub 2018 Nov 20. Leuk Lymphoma. 2019. PMID: 30457400
Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.
Konuma T, Kondo T, Mizuno S, Doki N, Aoki J, Fukuda T, Tanaka M, Sawa M, Katayama Y, Uchida N, Ozawa Y, Morishige S, Matsuoka KI, Ichinohe T, Onizuka M, Kanda J, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: katayama y. Biol Blood Marrow Transplant. 2020 Mar;26(3):463-471. doi: 10.1016/j.bbmt.2019.09.025. Epub 2019 Sep 25. Biol Blood Marrow Transplant. 2020. PMID: 31562960 Free article.
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.
Kaito S, Nakajima Y, Hara K, Toya T, Nishida T, Uchida N, Mukae J, Fukuda T, Ozawa Y, Tanaka M, Ikegame K, Katayama Y, Kuriyama T, Kanda J, Atsuta Y, Ogata M, Taguchi A, Ohashi K. Kaito S, et al. Among authors: katayama y. Blood Adv. 2020 Mar 24;4(6):1051-1061. doi: 10.1182/bloodadvances.2019000814. Blood Adv. 2020. PMID: 32191806 Free PMC article.
Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan.
Kida M, Usuki K, Uchida N, Fukuda T, Katayama Y, Kondo T, Eto T, Matsuoka KI, Matsuhashi Y, Ota S, Sawa M, Miyamoto T, Ichinohe T, Kimura T, Atsuta Y, Takami A, Miyazaki Y, Yano S, Ishiyama K, Yanada M, Aoki J. Kida M, et al. Among authors: katayama y. Biol Blood Marrow Transplant. 2020 Aug;26(8):1543-1551. doi: 10.1016/j.bbmt.2020.04.004. Epub 2020 Apr 19. Biol Blood Marrow Transplant. 2020. PMID: 32320746 Free article.
Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation.
Konuma T, Ishiyama K, Igarashi A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Matsuoka KI, Mori T, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation. Konuma T, et al. Among authors: katayama y. Clin Cancer Res. 2020 Dec 15;26(24):6483-6493. doi: 10.1158/1078-0432.CCR-20-1104. Epub 2020 Sep 6. Clin Cancer Res. 2020. PMID: 32895232
2,757 results